Vanja Hoeben – Head of Benelux, Aspen
Vanja Hoeben oversees the Benelux cluster for South Africa-headquartered specialty and branded pharma firm Aspen. He describes the reorganisation that his organisation has undergone in the past few years, some…
Address: Namur Office Park | Avenue des Dessus de Lives, 6 | B-5101 Loyers (Namur)
Tel: +32 81 33 28 50
Web: http://www.investinwallonia.be/?lang=en
Helping foreign investors to successfully set up and integrate their activities as part of the regional economic fabric.
The Foreign Investors division of the Agence Wallonne à l’Exportation et aux Investments étrangers (AWEX) (Walloon Exports and Foreign Investments Agency) is home to a multilingual team of expert consultants who are entirely at your service.
From an initial feasibility study all the way up to signing on the dotted line in concluding the investment, we provide personalised assistance geared to your needs and situation.
If you are a foreign investor looking to develop your activities in Wallonia, you can rest safe in the knowledge that our team of experts is there to assist you every step of the way.
Contact us!
Investor services : the point of single contact for all aspiring foreign investors seeking to set up business in Wallonia.
Our remit is:
to help you in seeking out appropriate sites and premises;to provide assistance with the start-up, development and diversification of your business;
to help you gain access to venture capital;
to provide advice and assistance in attracting suitable human resources;
to help you with setting up training programmes;
to provide assistance in obtaining subsidies from the Regional and European authorities;
to provide legal, tax and logistics support;
Vanja Hoeben oversees the Benelux cluster for South Africa-headquartered specialty and branded pharma firm Aspen. He describes the reorganisation that his organisation has undergone in the past few years, some…
Maria Fernanda Prado highlights some of the lessons drawn from her extensive experience in emerging markets which remain applicable in her current role as Janssen’s managing director for the Benelux…
Japanese-headquartered Takeda has been undergoing a transformation in recent years, becoming the global leader in rare diseases with the acquisition of Shire in 2018 and divesting ‘non-core’ assets in OTC…
Werner De Prins oversees Bayer’s operations in Benelux, a significant region for the global group with over 2000 employees, a turnover of around EUR 1.2 billion and 10 different sites…
Stefan Joris of the Belgian Cystic Fibrosis Association (BCFA) highlights the progress that has been made on cystic fibrosis screening of newborns and reimbursement of innovative modulator therapies in Belgium…
Dr Frank Nobels, one of Belgium’s leading endocrinologists and diabetologists, introduces the Belgian Diabetes Forum – a multi-stakeholder initiative which aims to create efficient policy engagement in diabetes and make…
With two in-house Clinical Research Units (PCRUs), Pfizer uniquely keeps its phase I research within the company. As Medical/Scientific advisor at the Brussels PCRU and with a history of more…
After almost 20 years with AbbVie, Renaud Decroix still feels as engaged and motivated as ever by the goal of having a remarkable impact on patients’ lives. Decroix highlights some…
Medaxes – the Belgian industry association for companies producing generic and biosimilar medicines, as well as other off-patent medicines and self-care products – welcomed a new CEO in 2022, Jasmien…
Théa veteran and GM of the French ophthalmology midcap’s BeLux affiliate, Ivan Perrichon, reveals the company’s plans to pursue its growth trajectory, launch ten new products in Belgium and reach…
Belgium is a hugely significant country for GSK – which employs 9,000 people in the country – as host to three of the firm’s major vaccine sites, the global headquarters…
Paul Newton of Vertex Pharmaceuticals – one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry – outlines the company’s footprint…
See our Cookie Privacy Policy Here
